- Home
- BRBS vs AMRN Comparison
BRBS vs AMRN Comparison
Compare BRBS & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BRBS | AMRN |
|---|---|---|
| Founded | 1893 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 355.2M | 287.9M |
| IPO Year | 2015 | 1998 |
Fundamental Metrics
Financial Performance| Metric | BRBS | AMRN |
|---|---|---|
| Price | $4.01 | $13.93 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.7M | 81.2K |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | ★ 24.78% | N/A |
| EPS Growth | ★ 135.48 | 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | $111,284,000.00 | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 123.99 | 39.22 |
| 52 Week Low | $3.23 | $12.96 |
| 52 Week High | $4.79 | $20.90 |
Technical Indicators
Market Signals| Indicator | BRBS | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 70.14 | 48.76 |
| Support Level | $3.88 | $13.59 |
| Resistance Level | $4.08 | $14.55 |
| Average True Range (ATR) | 0.07 | 0.56 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 64.06 | 39.42 |
Price Performance
Historical ComparisonAbout BRBS Blue Ridge Bankshares Inc.
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, and others. It generates the majority of its revenue from commercial banking.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.